Executive Chairman · Whitehawk Therapeutics, Inc. (WHWK)

Neil Desai

A named executive officer of Whitehawk Therapeutics in every fiscal year CompBrief holds from FY2021 to FY2023. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2023

$2,162,314

Salary $638,040Stock awards $0

FY2022: $3,052,812

1st of 5 named executive officers at Whitehawk Therapeutics by FY2023 total.

5 named officers on file for Whitehawk Therapeutics, FY2023

Neil Desai’s pay file — $29

  • 3 fiscal years of pay, line by line
  • 3 equity grants, each cited to its filing

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Whitehawk Therapeutics’s whole pay program stands against its peers

  • Whitehawk Therapeutics’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on WHWK→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 26, 2024 (DEF 14A). Insider transactions since that proxy, current to 2026-11-21.

Free

Get Neil Desai’s full pay file as a PDF — free

More than this page: up to 10 years of Neil’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Neil Desai compensation by year

Whitehawk Therapeutics Summary Compensation Table · all 3 fiscal years held
In US dollars, as Whitehawk Therapeutics reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2021FY2022FY2023
Salary$465,791$618,120$638,040
Bonus$394,000$0$0
Stock awards$0$0$0
Option awards$2,511,538$1,934,692$1,451,968
Non-equity incentive$315,000$500,000$72,306
Pension and deferred compensation$0$0$0
All other$53,939$0$0
Total$3,740,268$3,052,812$2,162,314

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Whitehawk Therapeutics, Inc. DEF 14A filed April 26, 2024, accession 0001628280-24-018546, and prior-year filings.

How this page was built: the Whitehawk Therapeutics, Inc. filed document, accession 0001628280-24-018546. Every figure is read from that document and cited to the page and table it appears in. Filed April 26, 2024.

$3.7M
$3.1M
$2.2M
FY21
FY22
FY23
SalaryBonusNon-equity incentiveOption awardsAll other

Equity holdings

unvested awards at FY2023 year-end
TypeUnvested unitsValue at year-endExercise price
Option5,947—$3.41
Option150,000—$12.31
Option89,425—$17.24
Option54,688—$27.67

Per the Outstanding Equity Awards at Fiscal Year-End table in Whitehawk Therapeutics, Inc.'s FY2023 proxy; value at the fiscal year-end close, as the company printed it.

Insider transactions since the last proxy

11 Form 4 lines since the FY2023 proxy (filed April 26, 2024)
current to 2026-11-21 · updated nightly
DateTransactionPlanSharesPriceHeld after
2026-06-12Grant or award derivative—38,040$0.0038,040
2025-06-12Grant or award derivative—40,006$0.0040,006
2024-09-03Sale—40,000$1.711,171,543
2024-08-05Sale—5,652$1.341,211,543
2024-08-02Sale—18,933$1.411,217,195
2024-08-01Sale—15,415$1.501,236,128
2024-07-02Sale—8,652$1.341,251,543
2024-07-01Sale—31,348$1.451,260,195

The 8 most recent of 11 lines, each as reported on the Form 4. "10b5-1" marks a trade the filing reports under a pre-arranged trading plan. View every Form 4 filing on EDGAR →

Whitehawk Therapeutics’s named executive officers, FY2023

as the company reported each
Named executive officerRoleFY2023 total
Neil Desai · this pageExecutive Chairman$2,162,314
David LennonPresident and Chief Executive Officer$2,135,688
Scott GiacobelloChief Financial Officer and Former Interim President and Chief Executive Officer$1,971,183
Brendan DelaneyFormer President and Chief Executive Officer$1,645,015
Loretta ItriChief Medical Officer$1,475,685

Board service

Whitehawk Therapeutics board · FY2023–FY2025
Director compensation in US dollars, as Whitehawk Therapeutics reports it. Most recent year first; a dash means the company reported no figure in that column.
Fiscal yearCash feesStock awardsOption awardsOtherTotal
FY2025$40,000$0$57,968$0$97,968
FY2023—————

Each year as the company reported it in Whitehawk Therapeutics's director compensation table. Totals are the company's own disclosed totals.

How this board is paid

Company policy: Whitehawk Therapeutics pays directors a $40,000 cash retainer and $58,000 in Options. As stated in Whitehawk Therapeutics's FY2025 proxy.

The full Whitehawk Therapeutics compensation record

free company brief

This page is one person within Whitehawk Therapeutics's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Whitehawk Therapeutics's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Neil Desai's compensation dossier · One-time report. No refunds.